CDT EQUITY INC
CDT · NASDAQ
Updated at 2026-10-14 09:34:49
- Today's High
- $0.61
- Today’s Low
- $0.41
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.70
- Previous Close
- $0.66
- Volume
- 373.02K
- Market Cap
- $742.18K
- P/E Ratio
- --
- EPS
- $-5,400.36
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Life Sciences Tools & Services
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 4581 TAMIAMI TRAIL NORTH, NAPLES, FL, UNITED STATES, 34103
- Country
- US
- Listing Date
- 2022-02-03
- Fiscal Year End
- December
- Shares Outstanding
- 660K
- CIK
- 0001896212
- Website
- www.cdtequity.com
Conduit Pharmaceuticals Inc. (CDT) is a clinical-stage biopharmaceutical company focused on creating innovative therapies for oncology and rare diseases, targeting significant unmet medical needs. Utilizing its proprietary drug delivery technology, Conduit aims to improve the efficacy and safety of existing treatments, thereby enhancing patient outcomes and reducing adverse effects. Supported by a seasoned management team and strategic collaborations, the company is well-positioned to advance its pipeline of transformative products, with the potential to significantly influence the healthcare landscape.
Financial Metrics
Revenue
2026-06-30
$750.15M
2026-03-31
$696.37M
2025-12-31
$2.71B
2025-09-30
$698.22M
Operating Expenses
2026-06-30
$183.65M
2026-03-31
$180.12M
2025-12-31
$21.15M
2025-09-30
$7.03M
Net Income
2026-06-30
$68.53M
2026-03-31
$51.02M
2025-12-31
-$21.32M
2025-09-30
-$7.11M
Net Profit Margin
2026-06-30
9.13%
2026-03-31
7.32%
2025-12-31
-0.78%
2025-09-30
-1.01%
Earnings Per Share
2026-06-30
$-8.71
2026-03-31
$-99.99
2025-12-31
$-57,860.32
2025-09-30
$-13.16
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$127.67M
2026-03-31
$108.68M
2025-12-31
-$18.87M
2025-09-30
-$6.18M
Effective Tax Rate
2026-06-30
19.56%
2026-03-31
18.7%
2025-12-31
-138.05%
2025-09-30
1.36%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $750.15M | $696.37M | $2.71B | $698.22M |
| Operating Expenses | $183.65M | $180.12M | $21.15M | $7.03M |
| Net Income | $68.53M | $51.02M | -$21.32M | -$7.11M |
| Net Profit Margin | 9.13% | 7.32% | -0.78% | -1.01% |
| Earnings Per Share | $-8.71 | $-99.99 | $-57,860.32 | $-13.16 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $127.67M | $108.68M | -$18.87M | -$6.18M |
| Effective Tax Rate | 19.56% | 18.7% | -138.05% | 1.36% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.